ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma

BACKGROUND: Breast cancer is a frequently occurring malignant tumor in women. Angiotensin‐converting enzyme 2 (ACE2) is widely expressed in most organs; however, the association of ACE2 with prognosis and immune infiltration in breast invasive carcinoma (BRCA) remains elusive. METHODS: We explored t...

Descripción completa

Detalles Bibliográficos
Autores principales: ling, Jie, Peng, Ning, luo, Lifei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169220/
https://www.ncbi.nlm.nih.gov/pubmed/35373393
http://dx.doi.org/10.1002/jcla.24362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169220/
https://www.ncbi.nlm.nih.gov/pubmed/35373393
http://dx.doi.org/10.1002/jcla.24362

Ejemplares similares